omniture
纽福斯(上海)生物科技有限公司

Latest News

Neurophth Closes RMB 400 Million Series B Financing

Proceeds to support – * continued development of robust portfolio of AAV-delivered therapeutics ...

2021-02-09 21:44 2224

Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer

WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ -- Wuhan Neurophth Biotechnology Ltd., a ...

2021-01-27 21:00 1791

Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy

WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidi...

2021-01-19 14:05 1854
12